Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyStem CellsMelphalanTreatment OutcomeBone Marrow TransplantationCyclophosphamideHematopoietic Stem Cell MobilizationEtoposideGraft vs Host DiseaseGraft SurvivalRemission InductionSalvage TherapyHematologic NeoplasmsMyeloablative AgonistsDisease-Free SurvivalAntigens, CD34RecurrenceHodgkin DiseaseHematopoietic Stem CellsLymphoma, Non-HodgkinSurvival RateLiver TransplantationCytarabineGranulocyte Colony-Stimulating FactorCarmustineWhole-Body IrradiationSurvival AnalysisBusulfanRetrospective StudiesThiotepaMesenchymal Stem Cell TransplantationVincristineBone Marrow PurgingTransplantation ChimeraTissue DonorsCord Blood Stem Cell TransplantationAmyloidosisLymphoma, Mantle-CellPrognosisCell TransplantationFollow-Up StudiesKidney TransplantationEmbryonic Stem CellsTime FactorsDoxorubicinDexamethasoneBoronic AcidsAntineoplastic Agents, AlkylatingPyrazinesAntibodies, Monoclonal, Murine-DerivedAdult Stem CellsLymphoma, FollicularLymphoma, T-Cell, PeripheralAntineoplastic AgentsLeukapheresisHistocompatibility TestingLeukemia, Myeloid, AcuteAutograftsImmunosuppressive AgentsThalidomideLymphomaIfosfamideNeoplasm, ResidualPrednisoneInduction ChemotherapyHistocompatibilityMyelodysplastic SyndromesCell DifferentiationPodophyllotoxinGraft vs Leukemia EffectHeart TransplantationLeukemiaPluripotent Stem CellsMesenchymal Stromal CellsLymphoma, Large B-Cell, DiffuseMaintenance ChemotherapyVidarabineTransplantation ImmunologyLung TransplantationNeural Stem CellsStem Cell NicheProspective StudiesGraft RejectionHematopoiesisHepatic Veno-Occlusive DiseaseBlood Component RemovalIdarubicinNeoplasms, Second PrimaryLymphoma, B-CellFatal OutcomeMitoxantroneInduced Pluripotent Stem Cells